Market reports, free public health charts and stories on cardiovascular, across every category we cover.
Our markets on cardiovascular, by category.
Worldwide reports first. Each covers 2024 history, a 2025 base year and forecasts to 2034.
Worldwide · 2024–2034
View report Medical DevicesWorldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report Medical DevicesWorldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report OTC & NutraceuticalsWorldwide · 2024–2034
View report OTC & NutraceuticalsWorldwide · 2024–2034
View report Medical DevicesWorldwide · 2024–2034
View reportLive data from public sources. The line shows the world (or US) trend.
2007–2021 · %
The chance that a 30-year-old dies before 70 from one of the four main long-term diseases.
Compare places2011–2025 · trials started
Clinical trials on heart and blood vessels that started each year with at least one site in the…
Compare placesMoney spent on heart and blood-vessel medicines for each person in a year, in US dollars adjusted…
Compare places2003–2017 · deaths per 100,000 people (age-adjusted)
Deaths from heart disease for every 100,000 people, adjusted so states with older people can be…
Compare placesStories and field notes on cardiovascular.
Named as key players in the most of these markets.
Medtronic4 markets here
Abbott Laboratories3 markets here
Boston Scientific Corporation3 markets here
Bristol-Myers Squibb Company3 markets here
Sanofi3 markets here
AstraZeneca2 markets here
Biotronik SE & Co. KG2 markets here
GE Healthcare2 markets here
Johnson & Johnson2 markets here
Koninklijke Philips N.V.2 markets here
AliveCor Inc.1 market here
Amgen Inc.1 market here
Each opens the market's statistics page, with every country we cover.
Medical Devices
OTC & Nutraceuticals
Pharmaceuticals
Full reports carry researched sizes, forecasts and company profiles. We also build custom studies.
Acuitas market figures are supplied with each full report. Chart data comes from the public sources named on each chart.